R9Q Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recce Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.284 EUR 1.43% Market Closed

Market Cap: €63m

	Recce Pharmaceuticals Ltd F:R9Q	AU
	China Resources Beer Holdings Co Ltd F:CHK0	HK
	Afya Ltd F:1AY	BR
L	Larimar Therapeutics Inc F:ZA71	US
G	Goldenbridge Acquisition Ltd NASDAQ:SDA	HK
D	Dunelm Group PLC F:DFQ	UK
	shipping corporation of India Ltd NSE:SCI	IN
A	Adidas AG F:ADS	DE
B	Baozun Inc F:2BZA	CN

Profitability Summary

Recce Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2.348%

Negative 3Y Average Operating Margin

-592%

Declining Operating Margin

-481% > -2.348%

Negative Net Margin

-2.671%

Negative 3Y Average Net Margin

-655%

Declining Net Margin

-482% > -2.671%

Negative Free Cash Flow Margin

-227%

Negative 3Y Average Free Cash Flow Margin

-166%

Free Cash Flow Margin is Increasing

-459% > -227%

Exceptional ROE

256%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-16.119%

ROIC is Increasing

-4.780% > 907%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.